Noninvasive automatic percutaneous dosing biotechnology

Abstract

The invention relates to a noninvasive automatic percutaneous dosing biotechnology. A device comprises a body shell, a dark matter graviton generating device, a container three-way valve and a medicine containing chamber. The graviton generating device comprises at least one dark matter graviton containing chamber, one end of the dark matter graviton containing chamber is connected with the container three-way valve, and the other end of the container three-way valve is connected with the medicine containing chamber. Compared with the prior art, medicine and dark matter graviton are jointly mixed and put into a portable special container, the biological electromagnetic field effect in the muscle-acupoint special complex microcirculation structure is excited through a dark matter graviton field, directional, accurate and rapid conveying can be achieved, the dosage of the medicine can be optimized, the medicine speed is adjusted, and accurate treating is achieved.

Description

technical field [0001] The invention relates to a non-invasive drug delivery system, in particular to a non-invasive transdermal automatic drug delivery biotechnology. Background technique [0002] At present, for the treatment of chronic diseases such as diabetes, daily subcutaneous insulin injections are often used, but this often leads to side effects such as pain, skin infection, subcutaneous congestion, formation of fat pads, abdominal obesity, and insulin resistance. Hypoglycemia leads to death. In order to solve the above problems, non-invasive and precise administration of insulin liquid is required. In 1995, the Robert Langer team at the Massachusetts Institute of Technology (MIT) developed a non-invasive drug delivery operation with low-frequency ultrasound to solve the problem of insulin injection. Through the cavitation effect of ultrasound in the liquid medicine, the cavitation bubbles will generate shock waves and micro jets, temporarily destroy the stratum co...

AI Technical Summary

Problems solved by technology

Among them, the properties of the liquid medicine can be changed by adding a penetration enhancer, but this change is abrupt and unstable. The sudden increase in the penetration rate and the interference of the liquid medicine effect by the penetration enhancer make this method unable to achieve continuous adjustment. However, increasing the ultrasonic power to increase the penetration rate may cause permanent damage to the skin or other biological tissues, and the purpose of non-invasive drug delivery cannot be achieved

Therefore, the current international low-frequency ultrasonic transdermal drug delivery technology is still unable to achieve precise and controllable non-invasive drug delivery, which affects the therapeutic rate and effect of drug delivery.

Images